Medicare Enrolled
Dr. Daniel Singer, D.O.
Neurology · Farmington Hills, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singer
Dr. Daniel Singer is a neurology specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Singer performed 8,266 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Singer received a total of $352,250 from 54 pharmaceutical and/or device companies across 952 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 5% volume in MI
$352,250 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,266
Medicare services
Top 5% in MI for neurology
Not available
Unique patients (not deduplicated)
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,800 | $5 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $89 | $208 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $58 | $144 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
210 | $123 | $269 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
151 | $65 | $115 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
113 | $106 | $206 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
89 | $199 | $613 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
79 | $84 | $221 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
56 | $292 | $854 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $131 | $264 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $143 | $323 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
36 | $115 | $452 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
20 | $162 | $505 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $132 | $421 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
14 | $24 | $110 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$352,250
Total received (2018-2024)
Avg $50,321/year across 7 years
Top 3% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
952
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,600
2023
$27,493
2022
$60,627
2021
$68,088
2020
$35,113
2019
$82,734
2018
$59,594
Payments by company (2024)
Biogen, Inc.
$9,094
ABBVIE INC.
$8,450
Sumitomo Pharma America, Inc.
$233
CATALYST PHARMACEUTICALS, INC.
$171
UCB, Inc.
$146
PFIZER INC.
$119
Novartis Pharmaceuticals Corporation
$81
Genentech USA, Inc.
$60
Teva Pharmaceuticals USA, Inc.
$57
Lilly USA, LLC
$47
TG Therapeutics, Inc.
$37
Grifols USA, LLC
$37
Eisai Inc.
$20
Azurity Pharmaceuticals, Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
CSL Behring
$16
Top 3 companies account for 95.6% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$136,111
Amgen Inc.
$96,568
ABBVIE INC.
$37,331
AbbVie Inc.
$36,489
Biohaven Pharmaceuticals, Inc.
$16,844
Biohaven Pharmaceutical Holding Company Ltd.
$14,382
Allergan, Inc.
$8,206
GENZYME CORPORATION
$519
UCB, Inc.
$515
Novartis Pharmaceuticals Corporation
$422
PFIZER INC.
$418
Genentech USA, Inc.
$381
Sunovion Pharmaceuticals Inc.
$374
CSL Behring
$370
Teva Pharmaceuticals USA, Inc.
$353
Sumitomo Pharma America, Inc.
$347
Grifols USA, LLC
$283
Lilly USA, LLC
$235
EMD Serono, Inc.
$205
Neurelis, Inc.
$196
CATALYST PHARMACEUTICALS, INC.
$171
Acorda Therapeutics, Inc
$147
Avanir Pharmaceuticals, Inc.
$122
Supernus Pharmaceuticals, Inc.
$112
ACADIA Pharmaceuticals Inc
$106
Celgene Corporation
$97
Lundbeck LLC
$93
Alexion Pharmaceuticals, Inc.
$76
US WorldMeds, LLC
$72
Allergan Inc.
$71
Takeda Pharmaceuticals U.S.A., Inc.
$66
Alnylam Pharmaceuticals Inc.
$46
Eisai Inc.
$42
Neurocrine Biosciences, Inc.
$42
LivaNova USA, Inc.
$41
TG Therapeutics, Inc.
$37
Corium, LLC
$37
Adamas Pharmaceuticals, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$30
Impax Laboratories, Inc.
$28
TG THERAPEUTICS, INC.
$22
EISAI INC.
$21
Mallinckrodt Hospital Products Inc.
$21
ARGENX US, INC.
$19
Cadwell Industries, INC
$18
AstraZeneca Pharmaceuticals LP
$17
OWP Pharmaceuticals, Inc.
$17
AbbVie, Inc.
$17
Azurity Pharmaceuticals, Inc.
$17
Promius Pharma LLC
$16
Horizon Therapeutics plc
$15
Tris Pharma Inc
$13
Zogenix Inc.
$13
Retrophin, Inc.
$1
Top 3 companies account for 76.7% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · Duopa · EMGALITY · Enspryng · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAYZENT · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · OCREVUS · ONPATTRO · OXTELLAR XR · Ocrevus · PAXLOVID · PLEGRIDY · QULIPTA · Quillivant XR · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Subvenite · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Xadago · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
356
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singer is a mixed practice specialist, with above-average Medicare volume (top 5% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singer experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Singer performed 6,800 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Singer receive payments from pharmaceutical companies?
Yes. Dr. Singer received a total of $352,250 from 54 companies across 952 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singer's costs compare to other neurologists in Farmington Hills?
Dr. Singer's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Farmington Hills
Browse neurologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology